Earnings Feed
Start Free
Home/Filings/4/0001140361-13-010678
4//SEC Filing

Ahn Chang Ho 4

Accession 0001140361-13-010678

CIK 0001228627other
View on SEC.govCompany Profile

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 4:16 PM ET

Size

9.5 KB

Accession

0001140361-13-010678

Insider Transaction Report

Form 4
Period: 2013-03-01
REXAHN PHARMACEUTICALS, INC.RNN
Ahn Chang Ho
DirectorChairman & CEO
Transactions
  • Award

    Stock Option (right to purchase)

    2013-03-01+250,000→ 250,000 total
    Exercise: $0.31Exp: 2023-03-01→ Common Stock (250,000 underlying)
Holdings

  • Common Stock

    (indirect: By Spouse)
    500,000

  • Common Stock

    6,813,924

  • Stock Option (right to purchase)

    Exercise: $0.78Exp: 2018-12-11→ Common Stock (500,000 underlying)
    500,000

  • Stock Option (right to purchase)

    Exercise: $0.80Exp: 2015-01-20→ Common Stock (1,000,000 underlying)
    1,000,000
Footnotes (3)
  • [F1]Options will vest and be exercisable based on the following schedule: 75,000 on March 1, 2014, 75,000 on March 1, 2015, and 100,000 on March 1, 2016.
  • [F2]Options vested and became exercisable based on the following schedule 150,000 on December 11, 2009, 150,000 on December 11, 2010, and 200,000 on December 11, 2011.
  • [F3]Options vested and became exercisable based on the following schedule 300,000 on January 20, 2006, 300,000 on January 20, 2007, and 400,000 on January 20, 2008.

Documents

1 file

Issuer

REXAHN PHARMACEUTICALS, INC.

CIK 0001228627

→
Entity typeother

Related Parties

1
  • filerCIK 0001316420

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:16 PM ET
Size
9.5 KB
View on SEC.gov